Yahoo Web Search

Search results

  1. People also ask

  2. Feb 13, 2024 · Learn about current and future Alzheimer's treatments that target beta-amyloid plaques, tau proteins and other factors in the brain. Find out how these medicines may slow or stop the disease progression and what side effects they may have.

  3. Jan 6, 2023 · January 06, 2023. Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the...

  4. Jun 5, 2023 · A drug that removes amyloid-beta from the brain, a key protein linked to Alzheimer's disease, slows its cognitive and functional decline in a trial. The trial results suggest a disease-modifying effect and a new hope for prevention or treatment of the disease, according to experts at Harvard Medical School and Brigham and Women's Hospital.

  5. Dec 20, 2023 · Home. News Releases. New Treatment Reverses Alzheimer’s Disease Signs. News Release. New Treatment Reverses Alzheimer’s Disease Signs. According to a preclinical study from Penn Medicine researchers, a molecular compound mimics the effect of natural chaperones that are depleted in the aging brain. December 20, 2023.

  6. Aug 9, 2021 · Immune cells, toxic protein tangles and brain waves are among the targets of future Alzheimer's treatments, scientists say. These approaches are noteworthy because they do not directly attack...

  7. Jul 24, 2023 · [Originally published January 19, 2023. Updated: July 24, 2023.] The Food and Drug Administration (FDA) recently granted full approval to a new Alzheimer’s treatment called lecanemab, which has been shown to moderately slow cognitive and functional decline in early-stage cases of the disease.

  1. People also search for